02/13/2019

IVI and Yonsei University College of Medicine’s IIID to collaborate in vaccine R&D

IVI Director General, Dr. Jerome Kim (right) shakes hands with Prof. Jeon-Soo Shin from Yonsei University College of Medicine’s IIID as they exchange MOU at IVI on February 12, 2019.   On February 12 IVI exchanged a memorandum of understanding with the Institute of Immunology […]
06/17/2019

IVI partners with QuadMedicine to develop microneedle-based vaccines

Dr. Jerome Kim (left), General Director of IVI and Mr. Seung-Ki Baek, CEO of QuadMedicine   June 17, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with QuadMedicine, a Korea-based biotech venture, to collaborate on the development of microneedle-based vaccines. With […]
07/12/2019

IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI)

    Dr. Jerome Kim (left), Director General of IVI and Dr. Quehn Park, Commander of AFMRI   July 12, 2019 – SEOUL, South Korea. Today IVI exchanged a memorandum of understanding with the Armed Forces Medical Research Institute (AFMRI), the Korean military’s institution dedicated […]
08/01/2019

IVI teams up with 4 Korean partners to nurture vaccine industry professionals

Representatives from five organizations, including IVI Director General Dr. Jerome Kim (second from left), pose for a commemorative photo as they exchange an MOU on the development of human resources and vaccine technology and industry at Andong National University in Gyeongsangbuk-do Province, Korea on July […]